AtriCure (ATRC) Tops Q4 EPS by 2c ; Offers Guidance
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.44 --0%
EPS Growth %: +92.3%
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +92.3%
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $106.5 million versus the consensus estimate of $103.37 million.
GUIDANCE:
AtriCure sees FY2024 EPS of ($0.74)-($0.82), versus the consensus of ($0.69). AtriCure sees FY2024 revenue of $459-466 million, versus the consensus of $458.4 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- KeyBanc Upgrades Nucor (NUE) to Overweight
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
